» Authors » A Chakrabarti

A Chakrabarti

Explore the profile of A Chakrabarti including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 303
Citations 4128
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Giri R, Mukhopadhyay M, Basak U, Chakrabarti A, Sanyal M, Runge B, et al.
J Phys Chem B . 2018 Jul; 122(30):7547-7554. PMID: 29983065
Drug design and targeted delivery in cells serve as a flourishing area not only for scientific inquiry, owing to numerous clinical applications, but also for understanding cell interaction with exogenous...
12.
Ullmann A, Aguado J, Arikan-Akdagli S, Denning D, Groll A, Lagrou K, et al.
Clin Microbiol Infect . 2018 Mar; 24 Suppl 1:e1-e38. PMID: 29544767
The European Society for Clinical Microbiology and Infectious Diseases, the European Confederation of Medical Mycology and the European Respiratory Society Joint Clinical Guidelines focus on diagnosis and management of aspergillosis....
13.
Espinel-Ingroff A, Turnidge J, Alastruey-Izquierdo A, Dannaoui E, Garcia-Effron G, Guinea J, et al.
Antimicrob Agents Chemother . 2018 Feb; 62(4). PMID: 29437624
Estimating epidemiological cutoff endpoints (ECVs/ECOFFS) may be hindered by the overlap of MICs for mutant and nonmutant strains (strains harboring or not harboring mutations, respectively). Posaconazole MIC distributions for the...
14.
Gawandi S, Gangawane S, Chakrabarti A, Kedare S, Bantwal K, Wadhe V, et al.
Indian J Clin Biochem . 2018 Jan; 33(1):81-85. PMID: 29371774
The prevalence of non-communicable diseases like diabetes mellitus (DM) and hypertension (HTN) is growing worldwide. Both lead to nephropathy if not controlled effectively. Microalbuminuria (MAU) is recognized as an early...
15.
Das P, Pandey P, Harishankar A, Chandy M, Bhattacharya S, Chakrabarti A
Indian J Med Microbiol . 2017 Oct; 35(3):381-388. PMID: 29063883
Purpose: Standardization of Aspergillus polymerase chain reaction (PCR) poses two technical challenges (a) standardization of DNA extraction, (b) optimization of PCR against various medically important Aspergillus species. Many cases of...
16.
Rotjanapan P, Chen Y, Chakrabarti A, Li R, Rudramurthy S, Yu J, et al.
Med Mycol . 2017 Oct; 56(3):387. PMID: 29040645
No abstract available.
17.
Perumal G, Ayyagari A, Chakrabarti A, Kannan D, Pati S, Grewal H, et al.
ACS Appl Mater Interfaces . 2017 Oct; 9(42):36615-36631. PMID: 28972737
Substrate-cell interactions for a bioimplant are driven by substrate's surface characteristics. In addition, the performance of an implant and resistance to degradation are primarily governed by its surface properties. A...
18.
Biswal M, Rudramurthy S, Jain N, Shamanth A, Sharma D, Jain K, et al.
J Hosp Infect . 2017 Sep; 97(4):363-370. PMID: 28939316
Background: Multidrug-resistant Candida auris infection has been reported from five continents in recent years. The prevalence of C. auris invasive infection has been estimated at 5.3% for intensive-care-acquired candidaemia in...
19.
Goel G, Chandy M, Bhattacharyya A, Banerjee S, Chatterjee S, Mullick S, et al.
Eur J Clin Microbiol Infect Dis . 2017 Aug; 36(12):2533-2535. PMID: 28801726
No abstract available.
20.
Espinel-Ingroff A, Abreu D, Almeida-Paes R, Brilhante R, Chakrabarti A, Chowdhary A, et al.
Antimicrob Agents Chemother . 2017 Jul; 61(10). PMID: 28739796
Clinical and Laboratory Standards Institute (CLSI) conditions for testing the susceptibilities of pathogenic species to antifungal agents are based on a collaborative study that evaluated five clinically relevant isolates of...